45.01 USD
-2.75
5.76%
At close Jul 11, 4:00 PM EDT
After hours
45.30
+0.29
0.64%
1 day
-5.76%
5 days
-5.90%
1 month
7.78%
3 months
-28.82%
6 months
-3.70%
Year to date
-2.91%
1 year
156.47%
5 years
147.99%
10 years
1,799.16%
 

About: Pro-Dex Inc is engaged in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used in the orthopedic, thoracic, and craniomaxillofacial (CMF) markets. The company also designs and manufactures multi-axis motion control systems used in factory automation and scientific research markets. Majority of the company's revenue is derived from designing, developing, and manufacturing surgical devices for the medical device and dental industries.

Employees: 148

0
Funds holding %
of 7,312 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

20% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 10

6% more capital invested

Capital invested by funds: $32M [Q4 2024] → $33.9M (+$1.95M) [Q1 2025]

2% more funds holding

Funds holding: 42 [Q4 2024] → 43 (+1) [Q1 2025]

8% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 12

0.07% more ownership

Funds ownership: 20.98% [Q4 2024] → 21.05% (+0.07%) [Q1 2025]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$56
24%
upside
Avg. target
$56
24%
upside
High target
$56
24%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Ascendiant Capital
Edward Woo
24%upside
$56
Buy
Maintained
27 May 2025

Financial journalist opinion

Based on 4 articles about PDEX published over the past 30 days

Positive
Zacks Investment Research
1 week ago
New Strong Buy Stocks for July 1st
NGD, GECC, MITSY, CWEN and PDEX have been added to the Zacks Rank #1 (Strong Buy) List on July 1, 2025.
New Strong Buy Stocks for July 1st
Positive
Zacks Investment Research
1 week ago
Best Value Stocks to Buy for July 1st
MITSY, NGD and PDEX made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 1, 2025.
Best Value Stocks to Buy for July 1st
Positive
Zacks Investment Research
3 weeks ago
Here is Why Growth Investors Should Buy ProDex (PDEX) Now
ProDex (PDEX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here is Why Growth Investors Should Buy ProDex (PDEX) Now
Positive
Zacks Investment Research
3 weeks ago
ProDex (PDEX) Upgraded to Buy: Here's Why
ProDex (PDEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ProDex (PDEX) Upgraded to Buy: Here's Why
Positive
Seeking Alpha
2 months ago
Pro-Dex: Crash After Strong Earnings Leads To A Buying Opportunity
Pro-Dex, Inc. experienced a 32% stock crash despite record Q3 2025 performance, presenting a buying opportunity for risk-tolerant investors. Q3 2025 revenue grew 22% YoY, with gross profit up 45% due to favorable product mix; operating income increased 64%. PDEX's PEG ratio of 0.27x indicates undervaluation compared to sector median, despite higher valuation multiples in other metrics.
Pro-Dex: Crash After Strong Earnings Leads To A Buying Opportunity
Positive
Zacks Investment Research
2 months ago
Pro-Dex, Inc. (PDEX) Q3 Earnings Surpass Estimates
Pro-Dex, Inc. (PDEX) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.47 per share. This compares to earnings of $0.19 per share a year ago.
Pro-Dex, Inc. (PDEX) Q3 Earnings Surpass Estimates
Neutral
Accesswire
2 months ago
Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results
IRVINE, CA / ACCESS Newswire / May 1, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 third quarter ended March 31, 2025.
Pro-Dex, Inc. Announces Fiscal 2025 Third Quarter and Nine-Month Results
Positive
Zacks Investment Research
2 months ago
ProDex (PDEX) Moves 5.1% Higher: Will This Strength Last?
ProDex (PDEX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ProDex (PDEX) Moves 5.1% Higher: Will This Strength Last?
Neutral
Zacks Investment Research
2 months ago
Take the Zacks Approach to Beat the Markets: Pro-Dex, Brookdale Senior Living, Coca-Cola in Focus
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Take the Zacks Approach to Beat the Markets: Pro-Dex, Brookdale Senior Living, Coca-Cola in Focus
Positive
Zacks Investment Research
3 months ago
ProDex (PDEX) Surges 7.4%: Is This an Indication of Further Gains?
ProDex (PDEX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ProDex (PDEX) Surges 7.4%: Is This an Indication of Further Gains?
Charts implemented using Lightweight Charts™